Rick E Winningham
2007 - Innoviva
In 2007, Rick E Winningham earned a total compensation of $2.3M as Chief Executive Officer at Innoviva, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $282,986 |
|---|---|
| Option Awards | $1,190,160 |
| Salary | $751,632 |
| Other | $36,422 |
| Total | $2,261,200 |
Winningham received $1.2M in option awards, accounting for 53% of the total pay in 2007.
Winningham also received $283K in non-equity incentive plan, $751.6K in salary and $36.4K in other compensation.
Rankings
In 2007, Rick E Winningham's compensation ranked 2,053rd out of 8,700 executives tracked by ExecPay. In other words, Winningham earned more than 76.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,053 out of 8,700 | 76th |
Division Manufacturing | 697 out of 3,314 | 79th |
Major group Chemicals And Allied Products | 133 out of 746 | 82nd |
Industry group Drugs | 71 out of 546 | 87th |
Industry Pharmaceutical Preparations | 54 out of 364 | 85th |
Source: SEC filing on March 24, 2010.
Winningham's colleagues
We found two more compensation records of executives who worked with Rick E Winningham at Innoviva in 2007.
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019